Polyclonal Rabbit anti‑Human FAD104 / FNDC3B Antibody (Azide‑free, aa176‑205, WB) LS‑C327379
Polyclonal Rabbit anti‑Human FAD104 / FNDC3B Antibody (Azide‑free, aa176‑205, WB) LS‑C327379
Antibody:
FAD104 / FNDC3B Rabbit anti-Human Polyclonal (aa176-205) (Azide-free) Antibody
Format:
Unconjugated, Azide-free
Overview
Antibody:
FAD104 / FNDC3B Rabbit anti-Human Polyclonal (aa176-205) (Azide-free) Antibody
Format:
Unconjugated, Azide-free
Specifications
Description
FNDC3B antibody LS-C327379 is an unconjugated rabbit polyclonal antibody to human FNDC3B (FAD104) (aa176-205). Validated for ELISA and WB.
Target
Human FAD104 / FNDC3B
Synonyms
FNDC3B | FAD104 | HCV NS5A-binding protein 37 | NS5ABP37 | YVTM2421 | PRO4979
Reactivity
Human
(tested or 100% immunogen sequence identity)
Conjugations
Unconjugated.
Also available conjugated with
APC,
FITC,
Biotin,
PE,
HRP.
Purification
Affinity purified
Modifications
Azide-free.
Also available
Azide-free.
Specificity
This FNDC3B antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 176-205 amino acids from the N-terminal region of human FNDC3B.
Applications
- Western blot (1:100 - 1:500)
- ELISA (1:1000)
Usage
The applications listed have been tested for the unmodified form of this product. Other forms have not been tested.
Presentation
PBS, 0.09% Sodium Azide
Storage
Short term: store at 4°C. Long term: aliquot and store at -20°C for up to 6 months. Avoid freeze-thaw cycles. Protect from light.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human
Applications:
IHC, IHC - Paraffin, ELISA
Species:
Human
Applications:
Western blot, ELISA
Species:
Human
Applications:
IHC, ELISA
Species:
Human
Applications:
IHC, ELISA
Reactivity:
Mouse
Range:
0.312-20 ng/ml
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 4/27/2024